SCHEMBL3721193

SCHEMBL3721193

NC(=O)Nc1ccccc1-c1ccnc(N2CCOCC2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 1/20 0.52
▸ CCNA2 P20248 1/20 0.52
▸ CDK2 P24941 1/20 0.52
▸ CDK9 P50750 1/20 0.52
▸ PIK3CA P42336 2/20 0.50
▸ PIK3CD O00329 1/20 0.50
▸ PIK3R1 P27986 1/20 0.50
▸ PIK3CB P42338 1/20 0.50
▸ PTPN11 Q06124 1/20 0.47
▸ POLB P06746 3/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ GPR55 Q9Y2T6 1/20 0.46
▸ HCAR2 Q8TDS4 1/20 0.46
▸ EIF2AK2 P19525 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.45
▸ ACHE P22303 2/20 0.45
▸ PRKCA P17252 1/20 0.44
▸ PRKCQ Q04759 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3802375 0.80 PIK3CA (0.57) PIK3CAPIK3CDPIK3R1PIK3CBMTOR
SCHEMBL3728169 0.79 PIK3CA (0.50) PIK3CAPIK3CDPIK3CBPOLBHSD17B10
SCHEMBL29484630 0.78 ALDH1A1 (0.56) PIK3CAPTPN11POLBHSD17B10HTT
SCHEMBL13555486 0.76 CCNT1 (0.56) CCNT1CCNA2CDK2CDK9PIK3CA
SCHEMBL6700332 0.74 PIK3CA (0.45) CCNT1CCNA2CDK2CDK9PIK3CA
SCHEMBL20920576 0.73 KDM4E (0.63) CCNT1CCNA2CDK2CDK9PIK3CA
SCHEMBL3721198 0.73 PTPN11 (0.56) PIK3CAPIK3R1PTPN11POLBHSD17B10
SCHEMBL3112205 0.73 HTT (0.58) CCNT1CCNA2CDK2CDK9PIK3CA
SCHEMBL4391823 0.73 JAK2 (0.72) JAK2
SCHEMBL5529145 0.72 PIK3CA (0.60) CCNT1CCNA2CDK2CDK9PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010120994-A2 UREIDOARYL-AND CARBAMOYLARYL-MORPHOLINO- PYRIMIDINE COMPOUNDS, THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS, AND THEIR SYNTHESIS WYETH LLC (US) 2010-10-21 — — WO disclosed
Send feedback